An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.
These findings are detailed in the new edition of Nature.
During 2014, the outbreak of the West African Makona strain of Ebola Zaire virus killed nearly 10,000 and caused worldwide concern. With increasing population growth in West Africa, the frequency of contact between humans and natural Ebola virus hosts such as bats will likely rise, potentially leading to more catastrophic outbreaks.
Many vaccine approaches have shown promise in being able to protect nonhuman primates against Ebola Zaire. In response to the Ebola Zaire outbreak, several of these vaccines have been fast tracked for human use.
One of those vaccines, developed by UTMB and Profectus, has been undergoing testing in the Galveston National Laboratory, the only fully operational Biosafety Level 4 laboratory on an academic campus in the U.S.
“These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks,” said Thomas Geisbert, UTMB professor of microbiology and immunology. “We are excited at the possibility of helping develop a way to stop this deadly disease. We have a lot of more work to accomplish but it’s important to note that this is a big step.”
The research team developed a vaccine effective against Ebola Zaire with a single dose in a nonhuman primate model. This new vaccine employs a virus not harmful to humans called vesicular stomatitis virus that had a part of the Ebola virus inserted into it. This “Trojan horse” vaccine safely triggered an immune response against Ebola Zaire.
To address any possible safety concerns associated with this vaccine, the team developed two next generation candidate vaccines that contain further weakened forms of the vaccine. Both of these vaccines produced an approximately ten-fold lower level of virus in the blood compared to the first generation vaccine.
“It was not known whether any of these vaccines could provide protection against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea,” said John Eldridge, Chief Scientific Officer-Vaccines at Profectus Biosciences, Inc. “Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virus.”
The Latest on: Ebola
via Google News
The Latest on: Ebola
- AHF Lauds WHO’s Belated Pre-Qualification of the Ebola Vaccineon November 14, 2019 at 4:20 pm
After more than four years of testing and vaccinations under compassionate use protocols, the most effective Ebola vaccine has at last received World Health Organization (WHO) pre-qualification, ...
- At Ebola ground zero in DR Congo, new vaccine offers hopeon November 14, 2019 at 10:17 am
Beni, Democratic Republic of Congo - This city in northeastern DRC has been on a high Ebola alert for nearly a year and a half since the latest outbreak started, killing more than 2,000 people.
- There is finally an approved Ebola vaccineon November 14, 2019 at 9:22 am
There’s big news this week in the fight against infectious disease: the world now has an approved Ebola vaccine. It is the first vaccine of its kind to be approved for quality, safety, and ...
- Rollout of Johnson & Johnson Ebola vaccine begins in Congoon November 14, 2019 at 3:56 am
GOMA, Congo (Reuters) - Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson & Johnson, aid group MSF said on Thursday, to help combat the world’s second-worst ...
- Ebola scare was just a simulation exercise, says Health Ministryon November 14, 2019 at 2:57 am
Johannesburg - The Department of Health in South Africa has confirmed that reports of a woman purportedly displaying Ebola symptoms were part of a simulation exercise in Lesotho. Media reports on ...
- Second Ebola vaccine introduced in DR Congoon November 14, 2019 at 12:59 am
The Democratic Republic of Congo on Thursday introduced a second vaccine to fight a 15-month-old epidemic of Ebola in the east of the country, Doctors Without Borders (MSF) said. The new vaccine, ...
- 1st Ebola vaccine gets full approvalon November 13, 2019 at 1:36 pm
Nov. 13 (UPI) --The World Health Organization has approved the world's first Ebola vaccine amid history's second largest outbreak of the disease in the Democratic Republic of Congo. WHO prequalified ...
- Ebola vaccine approved by WHO for first time everon November 13, 2019 at 10:52 am
Ebola is now officially preventable and treatable. Today the World Health Organization (WHO) prequalified an Ebola vaccine for the first time in the history of the world. The Ervebo vaccine is now ...
- Security Stymies Effort to End Ebola in Congoon November 13, 2019 at 7:47 am
GENEVA - The World Health Organization says that dangers posed by armed groups in two eastern Democratic Republic of Congo provinces are impeding progress in the battle to stop the spread of the ...
- Five reasons healthcare data security is at Ebola crisis levelson November 13, 2019 at 4:48 am
Lots of PHI, low security, and multiple entry points make hospitals the perfect target for hackers and ransomware attacks are up 45% in Q3. For doctors, X-rays and the machines that produce them are ...
via Bing News